This week should see the debut of three new publicly traded partnerships.
Westlake Chemical Partners�(expected ticker WLKP) was recently formed by�Westlake Chemical�(NYSE: WLK) to operate, acquire and develop ethylene production facilities and related assets. WLK is a manufacturer and supplier of petrochemicals, vinyls, polymers and building products produced at 16 plants across North America and one in China.
Westlake Chemical Partners��business and operations will be conducted through OpCo, a new Westlake affiliate in which WLKP will initially own a 10% limited partner stake as well as the general partner interest. WLK retained a 90% limited partner (LP) interest in OpCo and will own WLKP�� general partner and 55.7% of WLKP�� limited partner units, along with the incentive distribution rights.
OpCo�� assets will be comprised of three production facilities that convert ethane into ethylene, which is the world�� most widely used petrochemical in terms by volume. Aggregate annual capacity of the facilities is approximately 3.4 billion pounds. Assets also include the Longview Pipeline, a 200-mile ethylene pipeline with a capacity of 3.5 million pounds per day that runs from Mont Belvieu, Texas to the Longview, Texas chemical complex.
Best Prefered Companies To Own For 2015: American Axle & Manufacturing Holdings Inc. (AXL)
American Axle & Manufacturing Holdings, Inc., together with its subsidiaries, engages in the manufacture, engineering, design, and validation of driveline and drivetrain systems, and related components and chassis modules for automotive industry in the United States. The company?s driveline and drivetrain systems comprise components that transfer power from the transmission and deliver it to the drive wheels. These products include axles, chassis modules, driveshafts, power transfer units, transfer cases, chassis and steering components, driving heads, crankshafts, transmission parts, and metal-formed products. It offers products for light trucks, sport utility vehicles, passenger cars, crossover vehicles, and commercial vehicles. The company was founded in 1994 and is headquartered in Detroit, Michigan.
Advisors' Opinion:- [By Sue Chang]
American Axle & Manufacturing Holdings Inc. (AXL) �is projected to report earnings of 56 cents a share in the third quarter.
- [By Ben Levisohn]
This week we��e awaiting a court decision on whether GM might be ordered to issue a ��ark it��order for recalled vehicles awaiting an ignition fix. A negative ruling would mark another escalation. A more positive headline could emerge in late-Apr/early-May if GM were to take further steps to address impacted customers (i.e. fund). The headlines stemming from GM�� internal investigation are less predictable but also present a risk. Separately, if GM normalizes ATPs, some press reports may report it negatively as we��e seen all year. Tactically, our prior buy-on-weakness approach for GM, Ford and [American Axle & Manufacturing (AXL)] appeared to work last week and this remains our strategy as the situation unfolds.
- [By Ben Levisohn]
Weekend news likely prompts a negative reaction Monday, but Tues-Wed could go either way. GM stock could respond well if March share meets/beats expectations and if GM were to make adequate statements explaining concerns and offering remedies (OnStar can play role here). A sub-17% share and/or more negative revelations could pressure the stock further. We enter the week with a buy-on-weakness approach but acknowledge that this latest escalation adds ST market share risk. Thus, we also look to add positions in Buy-rated Ford (F) (possible ST share gains) and [American Axle & Manufacturing (AXL)] (pulled back + Q2 schedules appear intact).
- [By Seth Jayson]
American Axle & Manufacturing Holdings (NYSE: AXL ) is expected to report Q1 earnings on May 3. Here's what Wall Street wants to see:
Top 10 Net Payout Yield Stocks To Invest In Right Now: Aeon Metals Ltd (AQR)
Aeon Metals Limited is an Australia-based company. Its principal activity is exploration of the Rawbelle tenement for porphyry copper/molybdenum mineralization near Monto, Queensland. The principal project is the Greater Whitewash Polymetallic Project, which consists of four deposits over a strike length of five kilometers and width of one kilometer. Its other projects include Kiwi Carpet, Kildare Project, Juicy Fruit, and Anomaly 7B. As of June 30, 2012, it controlled seven contiguous exploration permits for minerals (EPMs): 14628, 15920, 15921, 15922, 17001, 17702, 17060, which are 100% held by the Company and three contiguous EPMs at Kidare: 14627, 15919, and 18202. During the fiscal year ended June 30, 2012 (fiscal 2012), it drilled 37 holes for 9,112 meters, being7, 440 meters reverse circulation (RC) and 1672 meters of diamond drilling (DD) on Rawbelle tenement. As of June 30, 2012, Kiwi Carpet porphyry copper area has had 20 drill holes which returned grades of copper. Advisors' Opinion:- [By Marc Chandler]
3. The flash euro area PMIs, due Thursday, stand out as the most market sensitive economic data from the euro area. Although the sentiment has been running ahead of real sector data, slight positive growth has replaced the recent contraction. Next Wednesday, the ECB is expected to unveil the broad details of the Asset Quality Review (AQR). This is not a stress test. It is a preliminary review of the books of the banks for which it will soon have supervisory responsibilities. Definitions of risk-weighted assets various in the euro area and some uniformity is a necessary condition of a banking union. New stress tests will be conducted next year.
Top 10 Net Payout Yield Stocks To Invest In Right Now: Eyes on The Go Inc (AXCG)
Eyes on the Go, Inc., incorporated on August 26, 2010, designs, implements, and provides services for the remote real-time monitoring of, and the control of equipment and devices located at, businesses and other facilities via computers, wireless handheld devices and television equipment using the Internet, through its Website, www.eyesonthego.com, or internal communications. As of May 1, 2011, the Company entered into a Plan and Agreement of Merger by and among the Company, Eyes Enterprises, Inc. and its wholly owned subsidiary, and EOTG, under which Enterprises was merged with and into EOTG, with EOTG being the surviving entity. As a result of this merger, the Company changed its name to Eyes on the Go, Inc. and EOTG changed its corporate name to Eyes Enterprises, Inc. On May 11, 2011 the Company completed a Plan and Agreement of Merger with Mutual Exchange Corp. The Company was considered to be the accounting acquirer, and the merger was accounted for as a reverse merger, whereby the Company being the accounting survivor.
Users of the Company�� services can view monitored facilities from video cameras, as well as receive temperature and other data; can remotely control devices, such as thermostats, lights and locks, and can receive e-mail-based alerts of door entries and other events with video clips and of equipment failures and deviations from temperature and other parameters. Its system can also store images and data for review. The Company markets primarily to business owners and managers in the hospitality industry.
The Company competes with Control4 Corporation, SVAT Electronics, Motorola, Inc., iControl Networks, Inc., Mi Casa Verde, Inc. and ADT Security Services, Inc.
Advisors' Opinion:- [By Peter Graham]
Last Friday, small cap stocks Kiwibox.com Inc (OTCMKTS: KIWB), Eyes on The Go Inc (OTCMKTS: AXCG) and Green Endeavors Inc (OTCMKTS: GRNE) were sinking 37.5%, 28.57% and 23.9%, respectively. Moreover, it should be mentioned that all three small cap stocks have been the subject of recent paid promotions or investor relation campaigns which have gotten them mentions in various investment newsletters or investor alerts. So are the promotional or investor relation campaigns over with for these three small caps? Here is a quick look to help you decide:
- [By Peter Graham]
Small cap stocks Eyes on The Go Inc (OTCMKTS: AXCG), Quadrant 4 Systems Corp (OTCMKTS: QFOR) and Cloud Security Corp (OTCMKTS: CLDS) were getting attention last week, but all three stocks trended downward on Monday. It should be mentioned that none of these stocks have been overly or heavily paid promotions. So what will these three small cap stocks do on the last trading day of the year and for the rest of this week? Here is a closer look:
Top 10 Net Payout Yield Stocks To Invest In Right Now: Onconova Therapeutics Inc (ONTX)
Onconova Therapeutics, Inc. (Onconova), incorporated on December 22, 1998, is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways, which promote cancer. It has three clinical-stage product candidates and six preclinical programs. Its preclinical pipeline includes six programs, which target kinases, cellular metabolism or division.
Rigosertib
Rigosertib, the Company�� product candidate, is being tested in a range of ongoing Phase-II and Phase-III clinical trials. The Company is conducting a pivotal phase-III trial of rigosertib under a Special Protocol Assessment (SPA), from the United States Food and Drug Administration (FDA), for higher risk myelodysplastic syndromes (MDS). The Company is also evaluating rigosertib in a Phase-III trial for metastatic pancreatic cancer, in two Phase-II trials for transfusion-dependent lower risk MDS, and in a Phase-II trial for head and neck cancers. Rigosertib has been granted orphan drug status for MDS in both the United States and Europe, as well as orphan drug status for pancreatic cancer in the United States. Baxter Healthcare SA (Baxter), a subsidiary of Baxter International Inc., has commercialization rights for rigosertib in Europe and SymBio Pharmaceuticals Limited (SymBio), has commercialization rights in Japan and Korea. Rigosertib is an inhibitor of two cellular signaling pathways: phosphoinositide 3-kinase (PI3K), and polo-like kinase (PLK), both of which are frequently over-active in cancer cells. By inhibiting the PI3K pathway in cancer cells, rigosertib promotes tumor cell apoptosis, or programmed cell death. It is testing both intravenous and oral formulations of rigosertib, referred to as rigosertib IV and rigosertib Oral, in clinical trials.
ON 013105
The Company�� clinical-stage product candidate, ON 013105, is i! n a Phase I trial in patients with relapsed or refractory lymphoma, including an aggressive form of non-Hodgkin's lymphoma identified as mantle cell lymphoma (MCL), and acute lymphoid leukemia (ALL). ON 013105 suppresses the accumulation of cyclin D1 in cancer cells.
Recilisib
The Company�� clinical-stage product candidate, recilisib, is being developed in collaboration with the United States Department of Defense (DoD), for acute radiation syndromes (ARS). The Company has completed four Phase-I trials to evaluate the safety and pharmacokinetics of recilisib in healthy human adult subjects using both subcutaneous and oral formulations, referred to as recilisib SC and recilisib Oral.
Preclinical Programs
The Company�� ON 1231320 is a specific inhibitor of Polo-like Kinase 2 (PLK2), and in preclinical studies, it induced mitotic arrest and reduced tumor burden in mice injected subcutaneously with colon tumor and triple-negative breast cancer cells. The Company�� ON 123300 inhibits the activity of two kinases, cyclin-dependent kinase 4 (CDK4), and AMP-activated protein kinase 5 (ARK5). Its ON 108600 is a dual inhibitor of two growth-regulatory kinases. Cyclin-dependent kinase 9 is over expressed in several cancers, including leukemias and lymphomas. Casein kinase 2 is overexpressed in a range of tumor types. ON 044580 inhibits mutant forms of the two target kinases, including Janus Kinase 2 (JAK2) and imatinib-resistant Bcr-Abl Kinase (Bcr-Abl). Its ON 24 compounds cause tubulin to depolymerize, inducing mitotic arrest in cultured tumor cell lines. Its ON 146040 inhibits the growth of a range of blood cancer cell lines, including Burkitt's lymphoma, MCL, multiple myeloma and chronic myeloid leukemia.
The Company competes with Eisai Inc., Celgene Corporation, Genentech, Inc., Cell Therapeutics, Inc., Cyclacel Pharmaceuticals, Inc., Telik, Inc., Spectrum Pharmaceuticals, Inc., Astex, Array BioPharma Inc., Astellas Pharma, Inc., Threshold! Pharmace! uticals, Inc., Pharmacyclics Inc., Soligenix, Inc., Cellerant Therapeutics, Inc. and Cleveland BioLabs, Inc.
Advisors' Opinion:- [By gurujx]
Onconova Therapeutics Inc (ONTX) Reached the 3-year Low of $4.18
The prices of Onconova Therapeutics Inc (ONTX) shares have declined to close to the 3-year low of $4.18, which is 86.8% off the 3-year high of $31.13.
- [By Roberto Pedone]
One under-$10 clinical-state biopharmaceutical player that's starting to move within range of triggering a big breakout trade is Onconova Therapeutics (ONTX), which focuses on discovering and developing small molecule drug candidates to treat cancer. This stock has been destroyed by the short-sellers so far in 2014, with shares off sharply by 56%.
If you glance at the chart for Onconova Therapeutics, you'll notice that this stock has been trending sideways and consolidating right below its 50-day moving average for the last few weeks. This consolidation pattern is occurring right after shares of ONTX recently spiked sharply higher from its low of $4.10 to its high of $5.52 a share. Shares of ONTX are now trending within range of breaking out of that consolidation pattern and potentially heading higher.
Traders should now look for long-biased trades in ONTX if it manages to break out above its 50-day moving average of $5.09 a share and then once it takes out some more key overhead resistance levels at $5.24 to $5.52 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 203,756 shares. If that breakout triggers soon, then ONTX will set up to re-test or possibly take out its next major overhead resistance levels at $6.27 to $7 a share.
Traders can look to buy ONTX off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $4.75 to right around $4.50 a share. One can also buy ONTX off strength once it starts to take out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Roberto Pedone]
Onconova Therapeutics (ONTX), a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drug candidates to treat cancer. This stock closed up 2.5% to $5.15 in Thursday's trading session.
Thursday's Range: $4.97-$5.19
52-Week Range: $4.10-$31.13
Thursday's Volume: 132,000
Three-Month Average Volume: 216,102From a technical perspective, ONTX trended modestly higher here with lighter-than-average volume. This stock has been uptrending over the last few weeks, with shares moving higher from its low of $4.10 to its recent high of $5.52. During that uptrend, shares of ONTX have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of ONTX within range of triggering a near-term breakout trade. That trade will hit if ONTX manages to take out Thursday's intraday high of $5.19 to some more key overhead resistance at $5.52 with high volume.
Traders should now look for long-biased trades in ONTX as long as it's trending above some near-term support levels at $4.80 or at $4.50 and then once it sustains a move or close above those breakout levels with volume that hits near or above 216,102 shares. If that breakout gets underway soon, then ONTX will set up to re-test or possibly take out its next major overhead resistance levels at $5.83 to $6.27. Any high-volume move above those levels will then give ONTX a chance to tag $7.
Top 10 Net Payout Yield Stocks To Invest In Right Now: Plains Exploration & Production Company(PXP)
Plains Exploration & Production Company, an independent oil and gas company, primarily engages in acquiring, developing, exploring, and producing oil and gas in California, Texas, and Louisiana. It owns oil and gas properties with principal operations in onshore California; offshore California; the Gulf Coast region, including Haynesville Shale, Eagle Ford Shale, and south and east Texas; the Mid-Continent region; and the Rocky Mountains. As of December 31, 2010, the company had estimated proved reserves of 416.1 million barrels of oil equivalent. Plains Exploration & Production Company was founded in 2002 and is headquartered in Houston, Texas.
Advisors' Opinion:- [By Matt DiLallo]
While it has diversity among metals, the company is also in the final stages of adding even more diversity among commodities. It has pending deals to acquire both McMoRan Exploration (NYSE: MMR ) and Plains Exploration and Production (NYSE: PXP ) . When the deals close, Freeport will shift its revenue mix from 100% mining related to around 75% mining and 25% oil and gas. That makes the company a truly diversified economic indicator as copper, oil, and natural gas are much more important to our economy than aluminum.
- [By Dan Caplinger]
1 (tie). Louisiana, March 29
Louisiana climbs to the top spot by keeping property taxes below $750 and collecting just a 4% sales tax, although local options add nearly 5 percentage points to that figure and make the state one of the highest-collecting sales-tax states. Although extensive activity from energy producers Chesapeake Energy (NYSE: CHK ) , Encana (NYSE: ECA ) , and Plains Exploration (NYSE: PXP ) in the Haynesville-Bossier shale play could boost incomes and lead to higher taxes, much of Louisiana's sales tax revenue comes from out-of-state tourists visiting the state, leaving the actual amount borne by residents even lower. A 6% income tax isn't enough to push Louisiana out of the top spot. - [By David Smith]
The pending purchases
Aside from its current core metals operations, Freeport is in the process of acquiring a pair of independent oil and gas producers, Plains Exploration & Production (NYSE: PXP ) and McMoRan Exploration (NYSE: MMR ) . In December, Freeport announced that it would pay 0.6531 shares of its common stock and $25 in cash for each outstanding share of Plains. In addition, for McMoRan it stated that it would pay $14.75 in cash and 1.15 units of a royalty trust that will hold a 5% overriding royalty interest in McMoRan's shallow water and ultra-deepwater prospects. - [By Rich Duprey]
Gold and copper miner�Freeport-McMoRan� (NYSE: FCX ) has completed its acquisition of Plains Exploration & Production (NYSE: PXP ) and, as previously planned, the board of directors says it will pay investors a supplemental dividend of $1.00 per share that is in addition to the regular quarterly payout of $0.3125 per share.
Top 10 Net Payout Yield Stocks To Invest In Right Now: Lexington Realty Trust (LXP)
Lexington Corporate Properties Trust operates as a self-managed and self-administered real estate investment trust (REIT). The company acquires, owns, and manages a portfolio of office, industrial, and retail properties net-leased to corporate tenants in the United States. It also provides investment advisory and asset management services to institutional investors in the net lease area. As of June 30, 2005, the company operated 185 properties and managed 2 properties. Lexington Corporate Properties Trust has elected to qualify as a REIT for federal income tax purposes. As a REIT, it would not be taxed on the portion of its income, which is distributed to shareholders, provided it distributes at least 90% of its taxable income. The company was founded in 1991 and is based in New York City.
Advisors' Opinion:- [By Brad Thomas]
Compared with the public REIT peers, I believe that Chambers Street will compare favorably to W.P. Carey (WPC) and Lexington Realty Trust (LXP). Both of these REITs own larger box assets and they both have conservative and well-positioned balance sheets. Here is a snapshot of Chambers Street's capitalization:
Top 10 Net Payout Yield Stocks To Invest In Right Now: Beeston Enterprises Ltd (BESE)
Beeston Enterprises Ltd, incorporated on July 12, 1999, is an exploration stage company that engages principally in the acquisition, exploration, and development of resource properties. The Company acquired a 100% interest in 19 mineral claims, comprising over 9,200 hectares, known as the Ruth Lake Property, located 25 kilometers from Lac La Hache, British Columbia, Canada. As of December 31, 2012, the Company owns five mineral claims in this area, all of which are in good standing.
The Company's British Columbia, Canada property is located in the Quesnel Trough. This belt is known for hosting skarn and porphyry copper and copper-gold deposits. The property is being investigated by the Company in Arizona, United States of America is also in a well known gold/silver mining area.
Advisors' Opinion:- [By Peter Graham]
Small cap stocks Beeston Enterprises Ltd (OTCMKTS: BESE) and HD Retail Solutions Inc (OTCMKTS: HDRE) surged 33.33% and 11.54%, respectively, on Black Friday while Frontier Beverage Company Inc (OTCMKTS: FBEC) sank 18.18%. And while Black Friday might be the most important shopping day of the year for retailers, its probably not a day that sees a lot of action from investors and traders still digesting their Thanksgiving meals (or busy looking for deals at their favorite retailers). So what direction will these three small cap stocks do for investors and traders this week? Here is a closer look to help you decide:
No comments:
Post a Comment